Publication | Open Access
Circulating Tumor Cells as a Tool of Minimal Residual Disease Can Predict Lung Cancer Recurrence: A longitudinal, Prospective Trial
51
Citations
34
References
2020
Year
CTC testing can potentially serve as a tool for minimal residual disease detection in early-staged lung cancer after curative surgery.
| Year | Citations | |
|---|---|---|
Page 1
Page 1